Literature DB >> 10894085

The specificity of platelet glutamate receptor supersensitivity in psychotic disorders.

M Berk1, H Plein, B Belsham.   

Abstract

Hypoglutamatergic function is implicated in the pathogenesis of schizophrenia, and supersensitivity of platelet NMDA receptors has been reported in schizophrenia. The aim of this study was to examine the platelet glutamate receptor sensitivity in patients with schizophrenia (n=12), mania with psychotic features (n=10) and depression with psychotic features (n=10) and matched controls (n=12) in order to assess if this is a marker of schizophrenia or occurs in other psychotic conditions. Glutamate receptor sensitivity was assessed using the intracellular calcium response to glutamate measured with spectrofluorometry. The percentage response of the schizophrenic and depressed psychotic subjects to glutamate stimulation was significantly greater than control subjects (p<0.005). The mania with psychotic features group was not significantly different to controls. This data suggests that platelet glutamate receptors may be supersensitive in schizophrenia and depression with psychotic features. Furthermore, the platelet may be a possible peripheral marker of glutamate function in schizophrenia and depression with psychotic features.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10894085     DOI: 10.1016/s0024-3205(00)80002-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

Review 1.  Platelets: A possible glance into brain biological processes in schizophrenia.

Authors:  Eyal Asor; Dorit Ben-Shachar
Journal:  World J Psychiatry       Date:  2012-12-22

Review 2.  Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications.

Authors:  Monojit Debnath; Michael Berk
Journal:  Schizophr Bull       Date:  2014-04-07       Impact factor: 9.306

3.  Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.

Authors:  Tatiana Barichello; Vijayasree Vayalanellore Giridharan; Gursimrat Bhatti; Pavani Sayana; Tejaswini Doifode; Danielle Macedo; Joao Quevedo
Journal:  Curr Top Behav Neurosci       Date:  2021

4.  The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis.

Authors:  Penelope Ae Main; Manya T Angley; Catherine E O'Doherty; Philip Thomas; Michael Fenech
Journal:  Nutr Metab (Lond)       Date:  2012-04-24       Impact factor: 4.169

Review 5.  Minocycline: therapeutic potential in psychiatry.

Authors:  Olivia M Dean; João Data-Franco; Francesco Giorlando; Michael Berk
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

Review 6.  Potential mechanisms of action of lithium in bipolar disorder. Current understanding.

Authors:  Gin S Malhi; Michelle Tanious; Pritha Das; Carissa M Coulston; Michael Berk
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

7.  The metabolism of serotonin in neuronal cells in culture and platelets.

Authors:  Kaneez Fatima Shad; Sheik Arshad Saeed
Journal:  Exp Brain Res       Date:  2007-11       Impact factor: 1.972

8.  The role of lamotrigine in the management of bipolar disorder.

Authors:  Felicity Ng; Karen Hallam; Nellie Lucas; Michael Berk
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

Review 9.  Using lithium as a neuroprotective agent in patients with cancer.

Authors:  Mustafa Khasraw; David Ashley; Greg Wheeler; Michael Berk
Journal:  BMC Med       Date:  2012-11-02       Impact factor: 8.775

10.  Glutamate mediates platelet activation through the AMPA receptor.

Authors:  Craig N Morrell; Henry Sun; Masahiro Ikeda; Jean-Claude Beique; Anne Marie Swaim; Emily Mason; Tanika V Martin; Laura E Thompson; Oguz Gozen; David Ampagoomian; Rolf Sprengel; Jeffrey Rothstein; Nauder Faraday; Richard Huganir; Charles J Lowenstein
Journal:  J Exp Med       Date:  2008-02-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.